2022
登陆港交所(9955.HK) Listed on the Hong Kong Stock Exchange(9955.HK)

智云健康在港交所上市,保持初心,始终以患者为中心,致力于让数字健康走进千家万户。截至2022年12月31日,合作医院逾2500家,合作药店逾19.3万家,注册用户约2850万 ClouDr has been listed on the Hong Kong Stock Exchange, maintaining its original mission, and always focusing on the patients. We are committed to bringing digital health into millions of households. As of December 31, 2022, we have partnered with over 2,500 hospitals and 193,000 pharmacies, with approximately 28.5 million registered users.

2020
打造数字化慢病管理生态 Building a Digital Chronic Disease Management Ecosystem

双SaaS系统、智云健康APP、智云医生APP等产品矩阵,已形成“医患药付”一站式慢病管理生态,公司实现自我造血,获得市场认可 The dual SaaS system, ClouDr APP, Dr ClouDr and other product matrices have formed a one-stop chronic disease management ecosystem of "doctors, patients, drug, payment". ClouDr has achieved self-growth and gained market recognition.

2018
爆发式成长 Explosive Growth

合作医院近1000家,业务收入实现300%的增长 Close to 1,000 partner hospitals; 300% growth in revenues Team expanded with many talents from leaders in the medical and internet industries, such as Johnson & Johnson, Kanghong Pharmaceutical, and Alibaba, among others

吸引大批来自强生、康弘药业、阿里巴巴等医疗与互联网头部公司优秀人才加入

2016
医院为先,进军医院SaaS系统 Hospital first strategy
公司进行战略转型,启动医院SaaS业务,发力服务医院与医生启动医院SaaS业务 Pivot to a SaaS-based business model, hoping to serve hospitals and doctors more systematically
2014
公司创立 Founding
杭州康晟健康管理咨询有限公司正式成立,希望通过先进互联网技术改善医患关系,提升医疗效率,帮助医疗资源合理分配

Hangzhou Kangsheng Health Management and Consulting Co., Ltd. founded.

Our mission: Leverage internet technologies to build stronger trust between doctors and patients, make healthcare more efficient and to improve the allocation of medical resources

2023
AI引擎提升数智化能力 AI Engine Enhance Digital Intelligence Capabilities

升级智云医疗大脑,推出两个医疗行业模型——ClouD GPT、ClouD DTx,持续用“AI+数字化”夯实科技创新底座,推动行业向数字化、智能化升级 The upgrade of the ClouDr Brain has led to the launch of two medical industry models - ClouD GPT and ClouD DTx. We strengthen our innovation foundation with “AI+Digitalization”, driving the industry towards digital and intelligent upgrades.

2021
数字化慢病管理的中国样本 Digital Chronic Disease Management: A Chinese Model

持续科技创新,提出“健康社区2030计划”,部署线下健康小站,建立了院内院外、线上线下联合的数字化慢病全生命周期管理的创新生态体系;正式成立中共智云健康支部委员会;公司创始人、董事长兼CEO匡明当选余杭区第十六届人大代表 Continuously innovating in technology, proposing the "Healthy Communities 2030 Plan", deploying health stations, and establishing an innovative ecosystem for digital chronic disease lifecycle management that integrates in-hospital and out-hospital, as well as online and offline services. Establish the Party Branch Committee of the Communist Party of China at ClouDr; Kuang Ming, the company's founder, chairman, and CEO, was elected as a delegate to the 16th People's Congress of Yuhang District.

2019
启动药店SaaS业务 Launch Pharmacy SaaS System

开拓院外场景,上线药店SaaS系统——智云问诊,年底前已覆盖3005家,持续拓展慢病生态链,全面提升技术与服务品质 Exploring out-of-hospital market and launch the pharmacy SaaS system, "ClouDr Consultation". By the end of the year, we have covered 3,005 pharmacies. We will expand the ecosystem of chronic disease management, aiming to comprehensively enhance technology and service quality.

2017
智云健康 ClouDr

智云银川互联网医院成立,品牌全面升级为“智云健康” Branding upgraded to ClouDr; Yinchuan e-Clinic created.

服务范围由糖尿病转为整个慢病领域,与近500家医院达成合作 Our scope expanding from diabetes to all chronic diseases; partnering with nearly 500 hospitals

核心用户超过500万人 Core users exceeded 5 million

2015
掌上糖医 APP for Diabetics
公司旗下第一款APP“掌上糖医”问世,凭借有效与易用特性成为广受认可的在线医疗平台之一;11月,服务糖尿病患者突破100万 Our first APP for diabetics launched, winning acclaim for its effectiveness and user-friendliness; by November, over 1 million diabetics were using the APP
发展历程 Our Journey